Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950123-11-092764
Filing Date
2011-10-28
Accepted
2011-10-28 10:37:15
Documents
8
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A b88699e10vqza.htm 10-Q/A 334256
2 EX-31.1 b88699exv31w1.htm EX-31.1 5619
3 EX-32.1 b88699exv32w1.htm EX-32.1 2641
  Complete submission text file 0000950123-11-092764.txt   1941510

Data Files

Seq Description Document Type Size
4 EX-101 INSTANCE DOCUMENT rxii-20110630.xml EX-101.INS 298584
5 EX-101 SCHEMA DOCUMENT rxii-20110630.xsd EX-101.SCH 18814
6 EX-101 CALCULATION LINKBASE DOCUMENT rxii-20110630_cal.xml EX-101.CAL 35381
7 EX-101 LABELS LINKBASE DOCUMENT rxii-20110630_lab.xml EX-101.LAB 139982
8 EX-101 PRESENTATION LINKBASE DOCUMENT rxii-20110630_pre.xml EX-101.PRE 83012
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-33958 | Film No.: 111163731
SIC: 2834 Pharmaceutical Preparations